Skip to main content
Retour
Watch Compare

BioScience Health Innovations, Inc.

Qualité des données : 100%
BHIC
OTC Technology Cloud & Data Services
2,15 €
▼ 0,06 € (-2,71%)
Cap. Boursière: 24,44 M
Prix
2,15 €
Cap. Boursière
24,44 M
Fourchette du Jour
2,15 € — 2,15 €
Fourchette 52 Semaines
0,52 € — 52,00 €
Volume
300
Ouverture 2,15 €
Moyenne 50J / 200J
3,48 €
38,17% below
Moyenne 50J / 200J
7,23 €
70,26% below

Quick Summary

Points Clés

Earnings grew 638,03% over the past year
ROE of 37,43% indicates high profitability
Generating 172 178,0 in free cash flow
P/E of 38,06 — premium valuation
ROIC of 27,55% — excellent capital efficiency

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)208,34%
Earnings (1Y)638,03%
FCF Growth (3Y)N/A

Qualité

Return on Equity
37,43%
Au-dessus de la moyenne du secteur (1,81%)
ROIC27,55%
Net Margin11,29%
Op. Margin12,64%

Sécurité

Debt / Equity
N/A
Current RatioN/A
Interest CoverageN/A

Valorisation

PE (TTM)
38,06
Au-dessus de la moyenne du secteur (-0,15)
P/B Ratio14,28
EV/EBITDA32,40
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Technology (1058 pairs)
Métrique Action Médiane du Secteur
P/E 38,1 -0,1
P/B 14,3 3,0
ROE % 37,4 1,8
Net Margin % 11,3 -0,5
Rev Growth 5Y % — 7,2
D/E — 0,4

All Fundamental Metrics
Growth
Revenue Growth (1Y) 208,34% Revenue Growth (3Y) 208,53%
Earnings Growth (1Y) 638,03% Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 5,69 M Net Income (TTM) 642 090,0
ROE 37,43% ROA 31,14%
Gross Margin 56,97% Operating Margin 12,64%
Net Margin 11,29% Free Cash Flow (TTM) 172 178,0
ROIC 27,55% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio N/A
Interest Coverage N/A Asset Turnover 2,76
Working Capital N/A Tangible Book Value 1,64 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 38,06 Forward P/E N/A
P/B Ratio 14,28 P/S Ratio 4,30
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 32,40 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 0,70%
Market Cap 24,44 M Enterprise Value 23,30 M
Per Share
EPS (Diluted TTM) 0,06 Revenue / Share 0,50
FCF / Share 0,02 OCF / Share 0,02
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 26,82%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 5,69 M 1,84 M 597 595,0 0,0 0,0
Net Income 642 090,0 87 000,0 -251 500,0 -83 208,0 -25 610,0
EPS (Diluted) 0,06 0,00 — — —
Gross Profit 3,24 M 1,31 M 484 407,0 — —
Operating Income 719 051,0 87 000,0 -251 500,0 -91 921,0 -25 610,0
EBITDA — — — — —
R&D Expenses 161 353,0 25 908,0 — — —
SG&A Expenses 2,21 M 1,15 M 706 257,0 91 921,0 25 610,0
D&A — — — — —
Interest Expense — — — 450,0 450,0
Income Tax 76 961,0 0,0 0,0 0,0 0,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 1,71 M 873 788,0 93 388,0 16 253,0 6 314,0
Total Liabilities 229 851,0 38 548,0 100 148,0 1 860,0 19 106,0
Shareholders' Equity 1,48 M 835 240,0 -6 760,0 14 393,0 -12 792,0
Total Debt — — — — —
Cash & Equivalents 661 925,0 662 517,0 19 238,0 — 2 035,0
Current Assets 1,56 M 847 751,0 93 388,0 16 253,0 6 314,0
Current Liabilities — — — — —